UBS Group’s Compute Health Acquisition Corp. CPUH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-35
Closed -$374 10301
2023
Q2
$374 Buy
35
+34
+3,400% +$356 ﹤0.01% 8269
2023
Q1
$10 Sell
1
-6,765
-100% -$69.3K ﹤0.01% 9465
2022
Q4
$68.3K Buy
6,766
+614
+10% +$6.14K ﹤0.01% 6468
2022
Q3
$61K Buy
6,152
+2,131
+53% +$21K ﹤0.01% 6162
2022
Q2
$39K Buy
4,021
+834
+26% +$8.18K ﹤0.01% 6126
2022
Q1
$31K Sell
3,187
-2,046
-39% -$20K ﹤0.01% 6979
2021
Q4
$51K Buy
5,233
+5,200
+15,758% +$50.8K ﹤0.01% 6884
2021
Q3
$0 Sell
33
-8,411
-100% -$81.8K ﹤0.01% 10352
2021
Q2
$83K Buy
8,444
+5,093
+152% +$50K ﹤0.01% 6028
2021
Q1
$33K Buy
+3,351
New +$32.9K ﹤0.01% 6937

UBS Group's CPUH Position: Q3 2023 in Review

UBS Group sold out of Compute Health Acquisition Corp. (CPUH) in Q3 2023, closing a stake of 35 shares — an estimated $374 sold.

UBS Group first reported a position in CPUH in Q1 2021 and held it in 10 quarters. The position peaked at $83K in Q2 2021. 0 funds tracked by Wall St. Rank hold CPUH as of Q3 2023.

  • UBS Group reported no remaining Compute Health Acquisition Corp. position as of Q3 2023 after selling out during the quarter.
  • UBS Group sold 35 Compute Health Acquisition Corp. shares in Q3 2023, an estimated $374.
  • UBS Group first reported a position in Compute Health Acquisition Corp. in Q1 2021 and held it in 10 quarters.
  • UBS Group's Compute Health Acquisition Corp. position peaked at $83K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.